Table 1.
Patient | Age (years) | Gender | Severity Score1 | Cholesterol mg/dl2 | 7-DHC mcg/ml2 | Genotype |
---|---|---|---|---|---|---|
1 | 5.4 | Male | 6 | 36 | 128 | c.964-1G>C/p.A247V |
2 | 4.6 | Female | 22 | 55 | 410 | p.T93M/p.R443C |
3 | 9.8 | Female | 6 | 100 | 26 | p.P51S/p.W151X |
4 | 6.3 | Female | 28 | 56 | 273 | c.964-1G>C/p.T93M |
5 | 11.9 | Female | 17 | 70 | 135 | c.964-1G>C/p.Y318N |
6 | 16.1 | Male | 11 | 117 | 59 | pC380Y/p.E448K |
7 | 13.0 | Male | 6 | 89 | 52 | c.964-1G>C/pT289I |
8 | 12.3 | Male | 28 | 18 | 80 | p.V326L/unk3 |
9 | 14.3 | Female | 17 | 94 | 81 | p.R242C/p.W177R |
10 | 19.9 | Female | 22 | 79 | 142 | c.964-1G>C/p.R352W |
See reference [Kelley and Hennekam, 2000]
Initial Values
Unknown. Sequencing of genomic DNA showed that the patient is heterozygous for the pV326L mutation. A second mutation was not detected in either coding regions or splice site junctions.